Discovery of small molecule agonists of the Relaxin Family Peptide Receptor 2
María Esteban-López(Dr. Herbert & Nicole Wertheim Family Foundation), Alexander I. Agoulnik(Florida International University), Elena M. Kaftanovskaya(Florida International University), Emmett R. George(National Institutes of Health), Noel Southall(National Center for Advancing Translational Sciences), Irina U. Agoulnik(University of South Florida), Wenjuan Ye(National Institutes of Health), Juan Marugán(National Institutes of Health), Roy Morello(University of Arkansas for Medical Sciences), Elena Barnaeva(National Center for Advancing Translational Sciences), Kenneth J. Wilson(National Institutes of Health), Mark J. Henderson(National Center for Advancing Translational Sciences), Xin Hu(Discovery Institute), Amy Wang(National Institutes of Health), Xin Xu(National Institutes of Health), Marc Ferrer(National Institute of Biomedical Innovation, Health and Nutrition), Courtney Myhr(Florida International University), John T. Sherrill(University of Arkansas for Medical Sciences)
Cited by 9
Related Papers
The Genome of <i>M. acetivorans</i> Reveals Extensive Metabolic and Physiological Diversity
|Genome Research|2002|634
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
|Nature Medicine|2016|570
Rethinking dog domestication by integrating genetics, archeology, and biogeography
|Proceedings of the National Academy of Sciences|2012|534
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
A transgenic insertion upstream of Sox9 is associated with dominant XX sex reversal in the mouse
|Nature Genetics|2000|351